Finith Jernigan, Ph.D. is an experienced professional who currently holds the position of Head of Molecular Design at Psivant Therapeutics. Prior to this, Finith served as a Principal at Roivant Sciences and held various positions at different companies including PTC Therapeutics, Inc. and Silicon Therapeutics. With a background in Chemistry, Finith has made significant contributions in the field of drug discovery through computational design and virtual screening efforts.
September, 2022 - present